BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28498248)

  • 1. C1GALT1 Seems to Promote In Vitro Disease Progression in Ovarian Cancer.
    Chou CH; Huang MJ; Liao YY; Chen CH; Huang MC
    Int J Gynecol Cancer; 2017 Jun; 27(5):863-871. PubMed ID: 28498248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.
    Hung JS; Huang J; Lin YC; Huang MJ; Lee PH; Lai HS; Liang JT; Huang MC
    Oncotarget; 2014 Apr; 5(8):2096-106. PubMed ID: 24758762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer.
    Lin MC; Chien PH; Wu HY; Chen ST; Juan HF; Lou PJ; Huang MC
    Oncogene; 2018 Oct; 37(43):5780-5793. PubMed ID: 29930379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.
    Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC
    Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
    Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
    Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.
    Chou CH; Huang MJ; Chen CH; Shyu MK; Huang J; Hung JS; Huang CS; Huang MC
    Oncotarget; 2015 Mar; 6(8):6123-35. PubMed ID: 25762620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered O-glycosylation is associated with inherent radioresistance and malignancy of human laryngeal carcinoma.
    Dong X; Luo Z; Wang Y; Meng L; Duan Q; Qiu L; Peng F; Shen L
    Exp Cell Res; 2018 Jan; 362(2):302-310. PubMed ID: 29179977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
    Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
    Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma.
    Chen Y; Ji Y; Shen L; Li Y; Ren Y; Shi H; Li Y; Wu Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):214. PubMed ID: 38662050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
    Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
    Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
    Chugh S; Barkeer S; Rachagani S; Nimmakayala RK; Perumal N; Pothuraju R; Atri P; Mahapatra S; Thapa I; Talmon GA; Smith LM; Yu X; Neelamegham S; Fu J; Xia L; Ponnusamy MP; Batra SK
    Gastroenterology; 2018 Nov; 155(5):1608-1624. PubMed ID: 30086262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin α
    Kuo TC; Wu MH; Yang SH; Chen ST; Hsu TW; Jhuang JY; Liao YY; Tien YW; Huang MC
    Oncogene; 2021 Feb; 40(7):1242-1254. PubMed ID: 33420364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin.
    Chen WC; Hsu HP; Li CY; Yang YJ; Hung YH; Cho CY; Wang CY; Weng TY; Lai MD
    Int J Oncol; 2016 Nov; 49(5):1881-1889. PubMed ID: 27633757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells.
    Chung WM; Chang WC; Chen L; Lin TY; Chen LC; Hung YC; Ma WL
    Stem Cell Res; 2014 Jul; 13(1):24-35. PubMed ID: 24793306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma.
    Lin NY; Chen ST; Chang HL; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Huang MC; Chang HH
    Oncogenesis; 2022 Feb; 11(1):8. PubMed ID: 35169131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.
    Zhang C; Deng X; Qiu L; Peng F; Geng S; Shen L; Luo Z
    J Cancer; 2018; 9(15):2666-2677. PubMed ID: 30087707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
    Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
    Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways.
    Khiaowichit J; Talabnin C; Dechsukhum C; Silsirivanit A; Talabnin K
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.